A Single-Center, Open-Label, Single-Dose Study To Assess The Pharmacokinetics, Safety, And Tolerability Of Moxidectin In Subjects Aged 4 To 11 Years ( '=12 kg) With Or Without Onchocerca Volvulus Infection

Trial Profile

A Single-Center, Open-Label, Single-Dose Study To Assess The Pharmacokinetics, Safety, And Tolerability Of Moxidectin In Subjects Aged 4 To 11 Years ( '=12 kg) With Or Without Onchocerca Volvulus Infection

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 26 May 2014

At a glance

  • Drugs Moxidectin (Primary)
  • Indications Onchocerciasis
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 26 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top